-+ 0.00%
-+ 0.00%
-+ 0.00%

SCIENTURE ANNOUNCES COMMERCIAL LAUNCH AND FULFILLMENT OF INITIAL PURCHASE ORDERS OF REZENOPY™, THE HIGHEST DOSE FDA-APPROVED NALOXONE NASAL SPRAY

Reuters·08/12/2026 12:05:00

Please log in to view news